Inferra AI / Company / EHC

Encompass Health Corp

EHC · Health Care

Last earnings Oct 28, 2026

AI analysis

Q3 2025 · reported Oct 29, 2025

Based on: Earnings release + parent 8-K — transcript not held

No extracted figures held

The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.

Guidance · company-stated

Direction: Raised

Revenue

“1 2025 Guidance The Company increased its full-year guidance as follows Full-Year 2025 Guidance Previous Guidance Updated Guidance (In Millions, Except Per Share Data) Net operating revenue $5,880 to $5,980 $5,905 to $5,955 Adjusted EBITDA $1,220 to $1,250 $1,235 to $1,255 Adjusted earnings per share from continuing operations attributable to Encompass Health $5.12 to $5.34 $5.22 to $5.37 For considerations regarding the Company s 2025 guidance, see the supplemental information posted on the Company s website at http investor.”

Company outlook — Raised

“com Encompass Health reports results for third quarter 2025 Increases full-year guidance BIRMINGHAM, Ala.”

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Such items include government, class action, and related settlements professional fees accounting, tax, and legal mark-to-market adjustments for stock appreciation rights gains or losses related to hedging instruments loss on early extinguishment of debt adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims) items related to corporate and facility restructurings and certain other items the Company believes to be not indicative of its ongoing operations.

However, the following reasonably estimable GAAP measures for 2025 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted Interest expense and amortization of debt discounts and fees - approximately $125 million Amortization of debt-related items - approximately $10 million The Q3 Earnings Form 8-K and, when filed, the September 2025 Form 10-Q can be found on the Company s website at http investor.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Encompass Health Corp Q3 2025 results

Based on: Earnings release + parent 8-K — transcript not held

Guidance & outlook

Direction: Raised

Revenue: “1 2025 Guidance The Company increased its full-year guidance as follows Full-Year 2025 Guidance Previous Guidance Updated Guidance (In Millions, Except Per Share Data) Net operating revenue $5,880 to $5,980 $5,905 to $5,955 Adjusted EBITDA $1,220 to $1,250 $1,235 to $1,255 Adjusted earnings per share from continuing operations attributable to Encompass Health $5.12 to $5.34 $5.22 to $5.37 For considerations regarding the Company s 2025 guidance, see the supplemental information posted on the Company s website at http investor.”

Company outlook — Raised (“Increases”)
“com Encompass Health reports results for third quarter 2025 Increases full-year guidance BIRMINGHAM, Ala.”

Revenue — Raised (“increased”)
“1 2025 Guidance The Company increased its full-year guidance as follows Full-Year 2025 Guidance Previous Guidance Updated Guidance (In Millions, Except Per Share Data) Net operating revenue $5,880 to $5,980 $5,905 to $5,955 Adjusted EBITDA $1,220 to $1,250 $1,235 to $1,255 Adjusted earnings per share from continuing operations attributable to Encompass Health $5.12 to $5.34 $5.22 to $5.37 For considerations regarding the Company s 2025 guidance, see the supplemental information posted on the Company s website at http investor.”

Classified from the release's primary full-year outlook statement.